Financial statements Laboratorium Obrazowania Molekularnego I Rozwoju Technologii Uniwersytetu Medycznego W Białymstoku
Cash flow statement of Laboratorium Obrazowania Molekularnego I Rozwoju Technologii Uniwersytetu Medycznego W Białymstoku
Company age:
Age:
10 y. 10 m. 10 d.
Share capital:
Share capital:
500 000 PLN
Cash inflows of LABORATORIUM OBRAZOWANIA MOLEKULARNEGO I ROZWOJU TECHNOLOGII UNIWERSYTETU MEDYCZNEGO W BIAŁYMSTOKU
|
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | 2 449 777,59 | 1 230 494,40 | - |
| Net cash flow from investing activities | - | - | - | -76 197,95 | -5 525 185,09 | - |
| Net cash flow from financial activities | - | - | - | -169,81 | -420,49 | - |
| Total net cash flow | - | - | - | 2 373 409,83 | -4 295 111,18 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.